Oral ketamine at home: what the evidence actually says

Oral ketamine is the fastest-growing and least-studied corner of ketamine treatment. It is cheaper than IV, more convenient than clinic visits, and increasingly offered as a supervised at-home protocol. It is also, in our editorial assessment, the route where marketing most outruns evidence.

What "oral ketamine" actually is

Tablets or sublingual lozenges (often compounded) prescribed at doses far below anesthetic levels. Two models exist:

• In-clinic oral dosing, where you take the dose under supervision — same safety logic as an infusion, milder effect, lower cost.
• Supervised at-home protocols, where you take doses at home on a schedule, with telehealth check-ins. This is the model under scrutiny in this article.

Either way, oral ketamine for depression, anxiety, PTSD, OCD, or pain is off-label. No ketamine-based medicine is FDA-approved for any of these conditions by mouth, and oral ketamine is not dispensed under any REMS program the way esketamine nasal spray is 1.

What the evidence shows — and doesn't

IV ketamine has randomized-trial support in treatment-resistant depression; oral ketamine has much less. The existing research on oral and sublingual ketamine is smaller, often uncontrolled, and uses varied doses and schedules, which makes effect sizes hard to pin down. There is also a pharmacological catch: ketamine swallowed or held under the tongue is absorbed less predictably than an IV dose, so identical tablets can produce meaningfully different blood levels between people and between doses. [Editorial interpretation based on the published literature.]

None of this means oral ketamine does not work for anyone. It means the honest answer to "does it work?" is "less certain than IV, and less certain than the marketing on telehealth sites suggests."

The risks specific to at-home dosing

The FDA label warns of sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors for ketamine-based medicines 1. At home, no one is monitoring any of these:

• No blood-pressure monitoring during a dosing window
• No supervision if a dose hits harder than expected
• Bladder risk — ketamine-induced cystitis is the best-documented harm of frequent repeated use, and daily oral dosing is exactly the pattern associated with it
• Misuse potential — a controlled substance in your medicine cabinet, on a daily schedule, with no oversight, is how misuse starts even in well-intentioned patients

This is why our safety guide treats at-home dosing as the highest-risk setup in ketamine care, and why vetting the prescribing clinic matters even more here than for infusions.

Questions to ask before starting an at-home protocol

• Who monitors me, and how often — actually, not nominally?
• What is the protocol if a dose makes me dangerously sedated or hypotensive?
• How will you monitor my bladder and urinary symptoms over months of dosing?
• What is your take-back or stop policy, and what screening ruled misuse risk in or out?
• What evidence supports this specific dose and schedule for my condition?

Where it fits

For patients who cannot access or afford IV treatment — see the cost comparison — a genuinely supervised oral protocol can be a reasonable middle path, ideally discussed with a prescriber who offers monitored in-clinic options too. Our complete 2026 ketamine guide compares all routes side by side.

If you are in crisis, call or text 988 for the Suicide & Crisis Lifeline.

Sources

1. FDA Prescribing Information for SPRAVATO® (esketamine), revised January 2025: https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/211243s016lbl.pdf. Evidence characterizations are editorial interpretation of the published literature, not a clinical recommendation.